This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ruygrok, P. N. Search for Related Content PubMed PubMed Citation Articles by Ruygrok, P. N.

CLINICAL STUDIES

Does angiography six months after coronary intervention influence management and outcome?

^a The Benestent Investigators and Cardialysis, Rotterdam, The Netherlands

Manuscript received February 4, 1999; revised manuscript received May 18, 1999, accepted June 29, 1999.

Reprint requests and correspondence: Dr. Peter Ruygrok, Catheterization Laboratory, Green Lane Hospital, Green Lane West, Epsom, Auckland, New Zealand
PRuygrok{at}ahsl.co.nz

OBJECTIVES

This study was performed to assess whether angiography six months after coronary balloon angioplasty or stent implantation has an influence on clinical management and one-year outcome.

BACKGROUND

The Benestent II study randomized 827 patients to balloon angioplasty or stent implantation. A subrandomization was undertaken allocating patients to six-month clinical follow-up (CF) or clinical and angiographic follow-up (AF).

METHODS

Seven hundred and six patients (349 CF and 357 AF) had no intercurrent angiography, so that restenosis and disease progression elsewhere remained unknown until the time of six-month follow-up. These two groups, which were well matched at enrolment, were compared with respect to symptoms, medication and major cardiac events defined as death, myocardial infarction and need for revascularization at six and 12 months.

RESULTS

At six-month follow-up, 53 (15%) of the CF and 76 (21%) of the AF patients had stable angina (p = 0.041), while 5 (1%) and 4 (1%) had symptoms of unstable angina. At 12-month follow-up, 44 (13%) patients in both groups had stable angina, and only 1 patient in the CF group had unstable angina. Seventy-seven patients (27 CF and 50 AF; p < 0.01) had major cardiac events between 6 and 12 months. Of the 349 patients in the CF group, 21 underwent repeat percutaneous transluminal coronary angioplasty or coronary artery bypass graft surgery between 6 and 12 months, compared with 44 of the 357 patients in the AF group (relative risk 2.05 [1.24 to 3.37], p = 0.003).

CONCLUSIONS

Patients who had AF six months after balloon angioplasty or stent implantation experienced more repeat revascularization procedures than those who had CF. They also had significantly more angina at six-month follow-up but this may be due to bias.

Abbreviations and Acronyms   AF = angiographic follow-up   CABG = coronary artery bypass graft surgery   CF = clinical follow-up   MI = myocardial infarction   PTCA = percutaneous transluminal coronary angioplasty

This article has been cited by other articles:

				S. G. Ellis, C. D. O'Shaughnessy, S. L. Martin, K. Kent, T. McGarry, M. A. Turco, D. J. Kereiakes, J. J. Popma, M. Friedman, J. Koglin, et al. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial Eur. Heart J., July 1, 2008; 29(13): 1625 - 1634. [Abstract] [Full Text] [PDF]

				E. Mahmud, G. Bromberg-Marin, V. Palakodeti, L. Ang, D. Creanga, and A. N. DeMaria Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2385 - 2395. [Abstract] [Full Text] [PDF]

				P. S. Teirstein Unprotected Left Main Intervention: Patient Selection, Operator Technique, and Clinical Outcomes J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 5 - 13. [Abstract] [Full Text] [PDF]

				A. M. Galloe, L. Thuesen, H. Kelbaek, P. Thayssen, K. Rasmussen, P. R. Hansen, N. Bligaard, K. Saunamaki, A. Junker, J. Aaroe, et al. Comparison of Paclitaxel- and Sirolimus-Eluting Stents in Everyday Clinical Practice: The SORT OUT II Randomized Trial JAMA, January 30, 2008; 299(4): 409 - 416. [Abstract] [Full Text] [PDF]

				T. Svilaas, I. C C van der Horst, and F. Zijlstra A quantitative estimate of bare-metal stenting compared with balloon angioplasty in patients with acute myocardial infarction: angiographic measures in relation to clinical outcome Heart, July 1, 2007; 93(7): 792 - 800. [Abstract] [Full Text] [PDF]

				M. Maeng, L. Okkels Jensen, K. Rasmussen, J. Flensted Lassen, L. Romer Krusell, P. Thayssen, and L. Thuesen Target lesion revascularisation in patients treated with a sirolimus-eluting or paclitaxel-eluting stent Heart, June 1, 2007; 93(6): 694 - 697. [Abstract] [Full Text] [PDF]

				A K Siotia, A C Morton, S Mofidi, C Wales, C Newman, and J Gunn Targeting drug-eluting stents to lesions at high risk of restenosis: a flawed approach? Heart, February 1, 2007; 93(2): 251 - 252. [Full Text] [PDF]

				A. T.L. Ong, J. Daemen, B. A. van Hout, P. A. Lemos, J. L. Bosch, R. T. van Domburg, and P. W. Serruys Cost-effectiveness of the unrestricted use of sirolimus-eluting stents vs. bare metal stents at 1 and 2-year follow-up: results from the RESEARCH Registry Eur. Heart J., December 2, 2006; 27(24): 2996 - 3003. [Abstract] [Full Text] [PDF]

				J. Fajadet, W. Wijns, G.-J. Laarman, K.-H. Kuck, J. Ormiston, T. Munzel, J. J. Popma, P. J. Fitzgerald, R. Bonan, R. E. Kuntz, et al. Randomized, Double-Blind, Multicenter Study of the Endeavor Zotarolimus-Eluting Phosphorylcholine-Encapsulated Stent for Treatment of Native Coronary Artery Lesions: Clinical and Angiographic Results of the ENDEAVOR II Trial Circulation, August 22, 2006; 114(8): 798 - 806. [Abstract] [Full Text] [PDF]

				A Bagust, A D Grayson, N D Palmer, R A Perry, and T Walley Cost effectiveness of drug eluting coronary artery stenting in a UK setting: cost-utility study Heart, January 1, 2006; 92(1): 68 - 74. [Abstract] [Full Text] [PDF]

				G. De Luca, H. Suryapranata, R. Grimaldi, and M. Chiariello Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction QJM, September 1, 2005; 98(9): 633 - 641. [Abstract] [Full Text] [PDF]

				P. Garot, T. Lefevre, M. Savage, Y. Louvard, W. R. Bamlet, J. T. Willerson, M.-C. Morice, and D. R. Holmes Jr Nine-Month Outcome of Patients Treated by Percutaneous Coronary Interventions for Bifurcation Lesions in the Recent Era: A Report From the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial J. Am. Coll. Cardiol., August 16, 2005; 46(4): 606 - 612. [Abstract] [Full Text] [PDF]

				H Suryapranata, G De Luca, A W J van 't Hof, J P Ottervanger, J C A Hoorntje, J-H E Dambrink, A T M Gosselink, F Zijlstra, and M-J de Boer Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients Heart, May 1, 2005; 91(5): 641 - 645. [Abstract] [Full Text] [PDF]

				A. T.L. Ong, P. W. Serruys, J. Aoki, A. Hoye, C. A.G. van Mieghem, G. A. Rodriguez-Granillo, M. Valgimigli, K. Sonnenschein, E. Regar, M. van der Ent, et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: One-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1135 - 1141. [Abstract] [Full Text] [PDF]

				B A van Hout, P W Serruys, P A Lemos, M J B M van den Brand, G-A v. Es, W K Lindeboom, and M-C Morice One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial Heart, April 1, 2005; 91(4): 507 - 512. [Abstract] [Full Text] [PDF]

				G. S. Werner, A. Krack, G. Schwarz, D. Prochnau, S. Betge, and H. R. Figulla Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2301 - 2306. [Abstract] [Full Text] [PDF]

				R. A. Hill, Y. Dundar, A. Bakhai, R. Dickson, and T. Walley Drug-eluting stents: an early systematic review to inform policy Eur. Heart J., June 1, 2004; 25(11): 902 - 919. [Abstract] [Full Text] [PDF]

				G. W. Stone, S. G. Ellis, D. A. Cox, J. Hermiller, C. O'Shaughnessy, J. T. Mann, M. Turco, R. Caputo, P. Bergin, J. Greenberg, et al. One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial Circulation, April 27, 2004; 109(16): 1942 - 1947. [Abstract] [Full Text] [PDF]

				N. E.J. West, P. N. Ruygrok, C. M.C. Disco, M. W.I. Webster, W. K. Lindeboom, W. W. O'Neill, N. F. Mercado, and P. W. Serruys Clinical and Angiographic Predictors of Restenosis After Stent Deployment in Diabetic Patients Circulation, February 24, 2004; 109(7): 867 - 873. [Abstract] [Full Text] [PDF]

				P. A. Lemos, P. W. Serruys, R. T. van Domburg, F. Saia, C. A. Arampatzis, A. Hoye, M. Degertekin, K. Tanabe, J. Daemen, T. K.K. Liu, et al. Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the "Real World": The Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry Circulation, January 20, 2004; 109(2): 190 - 195. [Abstract] [Full Text] [PDF]

				J. M. Brophy, P. Belisle, and L. Joseph Evidence for Use of Coronary Stents: A Hierarchical Bayesian Meta-Analysis Ann Intern Med, May 20, 2003; 138(10): 777 - 786. [Abstract] [Full Text] [PDF]

				N Mercado, W Maier, E Boersma, C Bucher, V de Valk, W.W O'Neill, B.J Gersh, B Meier, P.W Serruys, and W Wijns Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting: Implications for mechanical plaque sealing Eur. Heart J., March 2, 2003; 24(6): 541 - 551. [Abstract] [Full Text] [PDF]

				E. Van Belle, M. Perie, D. Braune, A. Chmait, T. Meurice, K. Abolmaali, E. P. McFadden, C. Bauters, J.-M. Lablanche, and M. E. Bertrand effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients J. Am. Coll. Cardiol., August 7, 2002; 40(3): 410 - 417. [Abstract] [Full Text] [PDF]

				P. N. Ruygrok, M. W.I. Webster, V. de Valk, G.-A. van Es, J. A. Ormiston, M.-A. M. Morel, and P. W. Serruys Clinical and Angiographic Factors Associated With Asymptomatic Restenosis After Percutaneous Coronary Intervention Circulation, November 6, 2001; 104(19): 2289 - 2294. [Abstract] [Full Text] [PDF]

				D. J. Cohen, M. Doucet, D. E. Cutlip, K. K.L. Ho, J. J. Popma, and R. E. Kuntz Impact of Smoking on Clinical and Angiographic Restenosis After Percutaneous Coronary Intervention: Another Smoker's Paradox? Circulation, August 14, 2001; 104(7): 773 - 778. [Abstract] [Full Text] [PDF]

				F. SCHIELE The "angioplastically correct" follow up strategy after stent implantation Heart, April 1, 2001; 85(4): 363 - 364. [Full Text]

				J. Al Suwaidi, P. B. Berger, and D. R. Holmes Jr Coronary Artery Stents JAMA, October 11, 2000; 284(14): 1828 - 1836. [Abstract] [Full Text] [PDF]